1/ 🧬 Today, we are featuring Dr. Serena Lucotti, an Early Career Researcher at Weill Cornell @cornelluniversity.bsky.social and chair of the MRS Early Career Leadership Council (ECLC). We spoke with Dr. Lucotti about her research and vision for the ECLC. 🧬
Alana Welm
@alanawelm.bsky.social
Professor, breast cancer metastasis research @Huntsman @UUtah; mom; collaborator; mentor; outdoor enthusiast
Join us for our next webinar as Dr. Maria Casanova-Acebes discusses her work on "TREM1-ing-metastasis lung immunity" - April 8th - 10:00 EST | 16:00 CET | 00:00 AEDT Sign-up today! us02web.zoom.us/webinar/register/WN_tVSpK...
1/8 The Metastasis Research Society’s mission is to support progressive research on processes fundamental to metastasis and connect researchers, clinicians, industry, advocates and patients. Learn more about the vision and research of our next President @netaerez.bsky.social 🧵👇
Thanks to those who politely pointed out we initially made a list of Metastasis Researchers... we've now made a starter pack! ☺️ go.bsky.app/KasKkhK Drop us a message or reply here to be added. More to follow over the coming days. 🦋
Thrilled to welcome #NativeAmerican & other indigenous leaders to @huntsmancancer.bsky.social today & discuss strategic planning for cancer control across rhe nation! @alanawelm.bsky.social @tomvarghesejr.bsky.social
I’m proud to have Marlon represent our lab!!
Congratulations to Marlon Lopez, a @utah.edu senior, who recently presented his research at Capitol Hill. As a lab aide in the Welm Lab, he contributes to metastatic breast cancer research. We appreciate his hard work and dedication and look forward to all he will accomplish! @alanawelm.bsky.social
Federal funding is critical to find cures for rare cancers - the NIH and NCI help fund such trials - because there is no profit in helping people with rare diseases. @huntsmancancer.bsky.social @tomvarghesejr.bsky.social @leonidasplatan1.bsky.social @alanawelm.bsky.social @uofutahcihd.bsky.social
In 2025, about 1 in 5 cancers diagnosed in the U.S. will be considered rare. Though uncommon individually, rare cancers impact over 400,000 people each year. This weekend, the Beacon of Hope shines in zebra stripes to honor Rare Disease Day and those affected by rare cancers.
I’m really grateful to live in a place where I can go out the backdoor for a slow paced 10mi run to clear my head of all this federal nonsense! I was especially lucky today to have a snowmobile track to run over; last week I had to break my own path. 1/2
And, at the end I saw a bald eagle perched on a tree! I hope you all can find whatever works to clear your head and get ready for another week of finding innovative ways to do, and fight for, science!
🧪👩🔬A new test to detect early stage pancreatic cancer may be on the horizon… if we as a country keep supporting scientific research.
Goosebump producing news this week out of Oregon Health and Science University in the diagnosis of pancreatic CA. They developed a groundbreaking blood test, called PAC-MANN. This new test can find pancreatic cancer in just 45 minutes, even in its earliest stages.
NSF employees were unlawfully reclassified from career to probationary, and then fired. www.reuters.com/world/us/us-...
US science agency reclassifies hundreds of workers as probationary, US lawmaker says
National Science Foundation administrators reclassified hundreds of employees from permanent to probationary status in violation of labor contracts, according to a U.S. lawmaker and agency employee.
reuters.com
The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer's and allergies.
NIH funding freeze stalls applications on $1.5 billion in medical research funds
The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer's and allergies.
npr.org
Use this form to tell us how the new US administration is affecting your research, or suggest future coverage https://go.nature.com/3EYNA8C
Are the Trump team’s actions affecting your research? How to contact Nature
Use this form to share information with Nature’s news team, or to make suggestions for future coverage.
go.nature.com
Exciting news! Dr. Anna Parks has received the ASH Junior Faculty Scholar Award, recognizing her outstanding research in hematology. This award supports her work in improving care for older adults with blood disorders. Congratulations, Dr. Parks, on this well-deserved honor! bit.ly/3D3lx7t
Anna Parks Receives American Society of Hematology Junior Faculty Scholar Award
Anna Parks, MD, was awarded the American Society of Hematology Junior Faculty Scholar Award, which supports promising early career hematologists committed to advancing the field through innovative res...
bit.ly
Add to that the priceless human impact of our research
A look at the economic impact of our research: 8,340 jobs created $248m in salaries & wages paid $328m in indirect labor income earned $32m in state & local taxes generated Learn more about the impact of #UofU research: www.research.utah.edu/facts-and-fi...
National Institutes of Health is the largest funder of research at @utah.edu supporting research on pressing issues from cancer to heart failure Without facilities & administrative (F&A) costs–or indirect costs–this research would not be possible. Learn more www.research.utah.edu/resources/fa...
Excellent article by many outstanding scientist who are members of the Metastasis Research Society!@metastasisresearch.bsky.social
FINALLY 🥁...our top most downloaded article of the year is…. 🥁🥁🥁 Why do patients with cancer die? By @tcox.bsky.social, Erik Sahai, et al. https://bit.ly/3WIyl... #metastasis #cancertherapy #cancermodels @crick.ac.uk @natureportfolio.bsky.social #NRCtop10of2024
From Harold Varmus (Former NIH and NCI Director and Nobel laureate) Why Would We Undermine the Marvel of American Science? www.nytimes.com/2025/02/14/o...
Opinion | American Science is Under Attack (Gift Article)
The Trump administration hobbles research and endangers the public health.
nytimes.com
Thrilled about this important federal grant to advance care for underserved #rural populations in #Utah! @alanawelm.bsky.social @tomvarghesejr.bsky.social @weldeiry.bsky.social @govcox.bsky.social
We are thrilled to announce that we have received funding to enhance care access in rural Utah. By expanding our Huntsman at Home™ model, this program will deliver advanced treatments, imaging, and clinical trial opportunities directly to patients in Grand, Emery & Carbon counties. bit.ly/41dycOw
We are thrilled to announce that we have received funding to enhance care access in rural Utah. By expanding our Huntsman at Home™ model, this program will deliver advanced treatments, imaging, and clinical trial opportunities directly to patients in Grand, Emery & Carbon counties. bit.ly/41dycOw
Wonderful explainer on indirect costs by Dick Aslin open.substack.com/pub/dickasli...
Are we paying too much for biomedical research?
Trump's attack on NIH
open.substack.com
Gene editing technology began by people studying salt marshes. Ozempic began by folks studying the venom of Gila Monsters. Support for basic science has empowered us to understand our world. Tethering it to applications health has transformed and saved countless lives.
Whenever you hear someone sneer about scientific research that seems useless to them — “they’re studying the spit of lizards?!” — remind them that’s exactly how we got Ozempic. globalnews.ca/news/9793403...
How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.
globalnews.ca
Be on the lookout for an appearance from yours truly during the Super Bowl pre-game (right before the National Anthem 🇺🇸) 👀
🦋Introductory post 🦋 The Metastasis Research Society (MRS) is a professional society for metastasis researchers. The MRS is dedicated to promoting research into all aspects of metastasis, and the exchange of information amongst key stakeholders including scientists, clinicians & patients.